Shilpa S Mehta
Overview
Explore the profile of Shilpa S Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitchell J, Cooperberg M, Elkin E, Lubeck D, Mehta S, Kane C, et al.
J Urol
. 2005 Mar;
173(4):1126-31.
PMID: 15758720
Purpose: Two methods widely used to predict the risk of treatment failure after radical prostatectomy for localized prostate cancer are the 3 level D'Amico risk classification and the Kattan nomogram....
2.
Cooperberg M, Lubeck D, Meng M, Mehta S, Carroll P
J Clin Oncol
. 2004 Jun;
22(11):2141-9.
PMID: 15169800
Purpose: Early intervention for prostate cancer is associated with excellent long-term survival, but many affected men, especially those with low-risk disease characteristics, might not experience adverse impact to survival or...
3.
Cooperberg M, Broering J, Litwin M, Lubeck D, Mehta S, Henning J, et al.
J Urol
. 2004 Mar;
171(4):1393-401.
PMID: 15017184
Purpose: The epidemiology and treatment of prostate cancer have changed dramatically in the prostate specific antigen era. A large disease registry facilitates the longitudinal observation of trends in disease presentation,...
4.
Mehta S, Lubeck D, Sadetsky N, Pasta D, Carroll P
J Urol
. 2003 Dec;
171(1):215-9.
PMID: 14665879
Purpose: Biochemical failure after definitive treatment for localized prostate cancer may occur in a substantial number of patients. The pattern and type of treatment offered to such patients have been...
5.
Kane C, Lubeck D, Knight S, Spitalny M, Downs T, Grossfeld G, et al.
Urology
. 2003 Dec;
62(6):1035-9.
PMID: 14665350
Objectives: To examine the effect of a patient's educational level on treatment selection for patients with newly diagnosed prostate cancer. A patient's educational level may impact a patient's understanding and...
6.
Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE
Meng M, Elkin E, Harlan S, Mehta S, Lubeck D, Carroll P
J Urol
. 2003 Nov;
170(6 Pt 1):2279-83.
PMID: 14634396
Purpose: Expectant management of prostate cancer or watchful waiting (WW) is a reasonable option for some men with clinically localized prostate cancer. We identified predictors of eventual prostate cancer treatment...
7.
Cooperberg M, Lubeck D, Mehta S, Carroll P
J Urol
. 2003 Nov;
170(6 Pt 2):S21-5.
PMID: 14610406
Purpose: Many instruments designed to predict prostate cancer risk use a combination of clinical T stage, biopsy Gleason score and serum prostate specific antigen (PSA). We designed a study to...
8.
Mehta S, Lubeck D, Pasta D, Litwin M
J Urol
. 2003 Oct;
170(5):1931-3.
PMID: 14532810
Purpose: Contemporary cancer treatments have resulted in patients living longer but with the risk of disease recurrence. Studies suggest that fear of recurrence is a significant burden. We described fear...
9.
Downs T, Sadetsky N, Pasta D, Grossfeld G, Kane C, Mehta S, et al.
J Urol
. 2003 Oct;
170(5):1822-7.
PMID: 14532784
Purpose: We measured the impact brachytherapy monotherapy (BMT) has on general and disease specific health related quality of life (HRQOL) compared to patients treated with radical prostatectomy (RP). Materials And...
10.
Harlan S, Cooperberg M, Elkin E, Lubeck D, Meng M, Mehta S, et al.
J Urol
. 2003 Oct;
170(5):1804-7.
PMID: 14532780
Purpose: Watchful waiting (WW) is one option for men with clinically localized prostate cancer. We examined temporal trends in the use of WW, as well as sociodemographic and clinical profiles...